These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20716214)

  • 1. Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review.
    Crijns HJ; Straus SM; Gispen-de Wied C; de Jong-van den Berg LT
    Br J Dermatol; 2011 Feb; 164(2):238-44. PubMed ID: 20716214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.
    Crijns I; Straus S; Luteijn M; Gispen-de Wied C; Raine J; de Jong-van den Berg L
    Drug Saf; 2012 Jan; 35(1):27-32. PubMed ID: 22050373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
    Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
    AlGhamdi KM; Khurram H; Asiri YA; Mandil A
    Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative review of the isotretinoin pregnancy risk management programs across four continents.
    Kovitwanichkanont T; Driscoll T
    Int J Dermatol; 2018 Sep; 57(9):1035-1046. PubMed ID: 29508918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
    Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
    Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.
    Lagan BM; Dolk H; White B; Uges DR; Sinclair M
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):411-8. PubMed ID: 24493556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral isotretinoin and pregnancy prevention programmes.
    Thiboutot D; Gollnick H; Bettoli V; Dréno B; Kang S; Leyden JJ; Shalita A; Torres V;
    Br J Dermatol; 2012 Feb; 166(2):466-7; author reply 467-8. PubMed ID: 21985025
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isotretinoin: compliance with recommendations in childbearing women].
    Bensouda-Grimaldi L; Jonville-Béra AP; Mouret E; Elefant E; Dhellot H; Delmas C; Gouin T; Coste P; Autret-Leca E;
    Ann Dermatol Venereol; 2005 May; 132(5):415-23. PubMed ID: 15988352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. We Pledge to Change iPLEDGE.
    Pierson JC; Ferris LK; Schwarz EB
    JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
    [No Abstract]   [Full Text] [Related]  

  • 12. Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.
    Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Sturkenboom MC; Straus SM; Stricker BH
    BMJ Open; 2014 Nov; 4(11):e005602. PubMed ID: 25392022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.
    Henry D; Dormuth C; Winquist B; Carney G; Bugden S; Teare G; Lévesque LE; Bérard A; Paterson JM; Platt RW;
    CMAJ; 2016 Jul; 188(10):723-730. PubMed ID: 27114489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy after isotretinoin use].
    Manders KC; de Vries LC; Roumen FJ
    Ned Tijdschr Geneeskd; 2013; 157(41):A6567. PubMed ID: 24103139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study.
    Crijns HJ; van Rein N; Gispen-de Wied CC; Straus SM; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1060-6. PubMed ID: 22228673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects].
    Mobacken H; Sundström A; Vahlquist A
    Lakartidningen; 2014 Jan 15-28; 111(3-4):93-6. PubMed ID: 24552013
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy outcomes and factors associated with voluntary pregnancy termination in women who had been treated for acne with isotretinoin.
    Yook JH; Han JY; Choi JS; Ahn HK; Lee SW; Kim MY; Ryu HM; Nava-Ocampo AA
    Clin Toxicol (Phila); 2012 Dec; 50(10):896-901. PubMed ID: 23116253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.